Clinical Evaluation of Bioactive Injectable Resin Composite in Posterior Restorations

NCT05499494 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2022-08-15

No results posted yet for this study

Summary

The aim of the study is to evaluate the clinical performance of new bioactive injectable composite compared to nanohybrid composite during the restoration of posterior cavities

Conditions

  • Dental Restoration Failure

Interventions

OTHER

Beautifil Flow Plus X F00 injectable composite

bioactive injectable composite

OTHER

Tetric N ceram resin composite

Nano hybrid resin composite

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mai Mamdouh, PhD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-31
Primary Completion
2024-02-29
Completion
2024-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05499494 on ClinicalTrials.gov